The stock of GoodRx Holdings Inc (NASDAQ: GDRX) has decreased by -6.56 when compared to last closing price of 4.27. Despite this, the company has experienced a -5.90% fall in its stock price over the last five trading sessions. zacks.com reported 2025-05-12 that Five Health and Fitness stocks to buy now are: SFM, DXCM, HIMS, UNFI, GDRX.
Is It Worth Investing in GoodRx Holdings Inc (NASDAQ: GDRX) Right Now?
The price-to-earnings ratio for GoodRx Holdings Inc (NASDAQ: GDRX) is above average at 53.70x. The 36-month beta value for GDRX is also noteworthy at 1.20. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 1 rating it as “overweight,” 7 rating it as “hold,” and 0 rating it as “sell.”
The public float for GDRX is 83.51M, and at present, short sellers hold a 4.88% of that float. The average trading volume of GDRX on May 15, 2025 was 1.72M shares.
GDRX’s Market Performance
GDRX stock saw a decrease of -5.90% in the past week, with a monthly decline of -11.14% and a quarterly a decrease of -20.68%. The volatility ratio for the week is 6.74%, and the volatility levels for the last 30 days are 5.56% for GoodRx Holdings Inc (GDRX). The simple moving average for the past 20 days is -10.18% for GDRX’s stock, with a -28.18% simple moving average for the past 200 days.
Analysts’ Opinion of GDRX
Many brokerage firms have already submitted their reports for GDRX stocks, with Mizuho repeating the rating for GDRX by listing it as a “Neutral.” The predicted price for GDRX in the upcoming period, according to Mizuho is $5 based on the research report published on December 04, 2024 of the previous year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $10. The rating they have provided for GDRX stocks is “Strong Buy” according to the report published on August 09th, 2024.
RBC Capital Mkts gave a rating of “Outperform” to GDRX, setting the target price at $10 in the report published on May 23rd of the previous year.
GDRX Trading at -10.67% from the 50-Day Moving Average
After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.91% of loss for the given period.
Volatility was left at 5.56%, however, over the last 30 days, the volatility rate increased by 6.74%, as shares sank -13.37% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.96% lower at present.
During the last 5 trading sessions, GDRX fell by -9.08%, which changed the moving average for the period of 200-days by -56.19% in comparison to the 20-day moving average, which settled at $4.44. In addition, GoodRx Holdings Inc saw -14.19% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GDRX starting from Bradley Julie MB, who proposed sale 95,255 shares at the price of $4.95 back on Dec 02 ’24. After this action, Bradley Julie MB now owns shares of GoodRx Holdings Inc, valued at $471,451 using the latest closing price.
Spectrum Equity VII, L.P., the 10% Owner of GoodRx Holdings Inc, sale 10,677 shares at $7.86 during a trade that took place back on Sep 03 ’24, which means that Spectrum Equity VII, L.P. is holding 0 shares at $83,922 based on the most recent closing price.
Stock Fundamentals for GDRX
Current profitability levels for the company are sitting at:
- 0.1 for the present operating margin
- 0.92 for the gross margin
The net margin for GoodRx Holdings Inc stands at 0.06. The total capital return value is set at 0.07. Equity return is now at value 4.43, with 2.07 for asset returns.
Based on GoodRx Holdings Inc (GDRX), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 2.72. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is 2.99.
Currently, EBITDA for the company is 153.92 million with net debt to EBITDA at -1.71. When we switch over and look at the enterprise to sales, we see a ratio of 1.47. The receivables turnover for the company is 4.98for trailing twelve months and the total asset turnover is 0.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.23.
Conclusion
In summary, GoodRx Holdings Inc (GDRX) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
